Perceptive Advisors »

Savara shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Savara (SVRA) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Savara

Tip: Access up to 7 years of quarterly data

All positions including Savara held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Savara by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $15M 2.4M 6.03

More positions owned by Perceptive Advisors

Praxis Precision Medicines I Com New (PRAX)
Celcuity (CELC)
Rhythm Pharmaceuticals (RYTM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apogee Therapeutics (APGE)
Roivant Sciences SHS (ROIV)
Nuvalent Inc-a (NUVL)
Travere Therapeutics (TVTX)
Spdr Series Trust State Street Spd Put Option (XBI)
EXACT Sciences Corporation
Protagonist Therapeutics (PTGX)
Inhibrx Biosciences (INBX)
Edgewise Therapeutics (EWTX)
Immatics SHS (IMTX)
Spyre Therapeutics Com New (SYRE)

View all positions for Perceptive Advisors

Top funds holding Savara

NEA Management Company
Bain Capital Life Sciences Investors
VR Adviser
Deerfield Management Company
TCG Crossover Management
BlackRock
Vanguard Group
Frazier Life Sciences Management
Polar Capital Holdings
Nantahala Capital Management
Rtw Investments
Marshall Wace
State Street Corporation
Woodline Partners
Emerald Advisers

View all funds holding Savara